On May 28, the Ministry of Natural Resources and seven other departments issued
the Guiding Opinions on Accelerating High-Quality Development of Marine Drugs
and Functional Products, the first national-level policy document on the marine
biopharmaceutical industry. The guidance directs coordinated strengthening of a
full-chain innovation system covering the "resource chain + science and
technology chain + industry chain + application chain", and calls for deep
integration of scientific/technological innovation and industrial innovation. It
sets targets to 2030 for multiple marine innovative drugs to reach the market
and for industry added value to surpass 130 bln yuan.